Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia
Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the non-inferiority of a topical Imiquimod
therapy in patients with persistent CIN 2/3 when compared to standard therapy, i.e.
conization A randomized, controlled, non-inferiority AGO-Austria trial
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Vienna
Collaborators:
Krankenhaus Barmherzige Schwestern Linz Medical University Innsbruck Medical University of Graz Salzburger Landeskliniken